Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kiss Industries
London, United Kingdomkisstherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Kiss Therapeutics is a biotechnology company focused on developing novel therapies for reproductive health and endocrine disorders by targeting the kisspeptin pathway. The company's research centers on kisspeptin analogs, which act as potent stimulators of the hypothalamic-pituitary-gonadal axis, essential for regulating human fertility. Their lead programs aim to provide more physiological treatments for conditions such as infertility, polycystic ovary syndrome (PCOS), and various forms of hypogonadism. By leveraging deep expertise in kisspeptin biology, Kiss Therapeutics seeks to offer alternatives to traditional hormone replacement therapies and assisted reproductive technologies.
- Therapeutic areas
- EndocrinologyWomen's Health
- Modalities
- PeptidesSmall molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Kiss Industries.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kiss Industries.